Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2026-02-05 @ 7:24 AM
Study NCT ID:
NCT02855892
Status:
COMPLETED
Last Update Posted:
2022-03-04
First Post:
2016-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH
Sponsor:
GemVax & Kael
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KG 3/2014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None